BACKGROUND: Rotavirus vaccine efficacy is reduced in low-income populations, but efforts to improve vaccine performance are limited by lack of clear correlates of protection. While plasma rotavirus (RV)-specific IgA appears strongly associated with protection against rotavirus gastroenteritis in high-income countries, weaker association has been observed in low-income countries. We tested the hypothesis that lower RV-specific IgA is associated with rotavirus vaccine failure in Malawian infants. METHODS: In a case-control study we recruited infants presenting with severe rotavirus gastroenteritis following monovalent oral rotavirus vaccination (RV1 vaccine failures). Conditional logistic regression was used to determine the odds of rotavirus...
BACKGROUND: Rotavirus is the most common cause of severe gastroenteritis among young children worldw...
Atypical DS-1-like G1P[8] rotaviruses emerged in 2013 in Malawi after rotavirus vaccine introduction...
Identifying risk factors for impaired oral rotavirus vaccine (ORV) efficacy in low-income countries ...
BackgroundRotavirus vaccine efficacy is reduced in low-income populations, but efforts to improve va...
IntroductionLive attenuated oral vaccines against rotavirus (RV) have been shown to be less efficaci...
BACKGROUND: Rotavirus is the main cause of severe acute gastroenteritis in children in Africa. Monov...
SummaryBackgroundRotavirus is the main cause of severe acute gastroenteritis in children in Africa. ...
Horizontal transmission of rotavirus vaccine virus may contribute to indirect effects of rotavirus v...
Background: Rotavirus vaccines have been introduced in many low-income African countries including M...
Background. Rotavirus vaccines have been introduced in many low-income African countries including M...
Background: Rotavirus is the main cause of severe acute gastroenteritis in children in Africa. Mo...
Deployment of rotavirus vaccines has contributed to significant declines in diarrheal morbidity and ...
BACKGROUND: Rotavirus vaccines have been introduced in many low-income African countries including M...
Rotavirus vaccines have been introduced in many low-income African countries including Malawi in 201...
Atypical DS-1-like G1P[8] rotaviruses emerged in 2013 in Malawi after rotavirus vaccine introduction...
BACKGROUND: Rotavirus is the most common cause of severe gastroenteritis among young children worldw...
Atypical DS-1-like G1P[8] rotaviruses emerged in 2013 in Malawi after rotavirus vaccine introduction...
Identifying risk factors for impaired oral rotavirus vaccine (ORV) efficacy in low-income countries ...
BackgroundRotavirus vaccine efficacy is reduced in low-income populations, but efforts to improve va...
IntroductionLive attenuated oral vaccines against rotavirus (RV) have been shown to be less efficaci...
BACKGROUND: Rotavirus is the main cause of severe acute gastroenteritis in children in Africa. Monov...
SummaryBackgroundRotavirus is the main cause of severe acute gastroenteritis in children in Africa. ...
Horizontal transmission of rotavirus vaccine virus may contribute to indirect effects of rotavirus v...
Background: Rotavirus vaccines have been introduced in many low-income African countries including M...
Background. Rotavirus vaccines have been introduced in many low-income African countries including M...
Background: Rotavirus is the main cause of severe acute gastroenteritis in children in Africa. Mo...
Deployment of rotavirus vaccines has contributed to significant declines in diarrheal morbidity and ...
BACKGROUND: Rotavirus vaccines have been introduced in many low-income African countries including M...
Rotavirus vaccines have been introduced in many low-income African countries including Malawi in 201...
Atypical DS-1-like G1P[8] rotaviruses emerged in 2013 in Malawi after rotavirus vaccine introduction...
BACKGROUND: Rotavirus is the most common cause of severe gastroenteritis among young children worldw...
Atypical DS-1-like G1P[8] rotaviruses emerged in 2013 in Malawi after rotavirus vaccine introduction...
Identifying risk factors for impaired oral rotavirus vaccine (ORV) efficacy in low-income countries ...